Journal of Vaccine Research 2024, Vol.14, No.4, 207-216 http://medscipublisher.com/index.php/jvr 215 Bezbaruah R., Chavda V. P., Nongrang L., Alom S., Deka K., Kalita T., Ali F., Bhattacharjee B., and Vora L., 2022, Nanoparticle-based delivery systems for vaccines, Vaccines, 10(11): 1946. https://doi.org/10.3390/vaccines10111946 PMid:36423041 PMCid:PMC9694785 Bhardwaj A., Sharma R., and Grover A., 2023, Immuno-informatics guided designing of a multi-epitope vaccine against Dengue and Zika, Journal of Biomolecular Structure and Dynamics, 41(1): 1-15. https://doi.org/10.1080/07391102.2021.2002720 PMid:34796791 Brewer N.T., 2021, What works to increase vaccination uptake, Academic Pediatrics, 21(4): S9-S16. https://doi.org/10.1016/j.acap.2021.01.017 PMid:33958099 Brisse M., Vrba S., Kirk N., Liang Y., and Ly H., 2020, Emerging concepts and technologies in vaccine development, Frontiers in Immunology, 11: 583077. https://doi.org/10.3389/fimmu.2020.583077 PMid:33101309 PMCid:PMC7554600 Chen J., Chen J., and Xu Q., 2022, Current developments and challenges of mRNA vaccines, Annual Review of Biomedical Engineering, 24(1): 85-109. https://doi.org/10.1146/annurev-bioeng-110220-031722 PMid:35231177 de la Fuente J., and Contreras M., 2021, Vaccinomics: a future avenue for vaccine development against emerging pathogens, Expert Review of Vaccines, 20(12): 1561-1569. https://doi.org/10.1080/14760584.2021.1987222 PMid:34582295 Flaxman A., Sebastian S., Appelberg S., Cha K.M., Ulaszewska M., Purushotham J., Gilbride C., Sharpe H., Spencer A.J., Bibi S., Wright D., Schmidt I., Dowall S., Easterbrook L., Findlay-Wilson S., Gilbert S., Mirazimi A., and Lambe T., 2024, Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse, PLoS Pathogens, 20(6): e1012262. https://doi.org/10.1371/journal.ppat.1012262 PMid:38924060 PMCid:PMC11233014 Gebre M., Brito L., Tostanoski L., Edwards D., Carfi A., and Barouch D.H., 2021, Novel approaches for vaccine development, Cell, 184(6): 1589-1603. https://doi.org/10.1016/j.cell.2021.02.030 PMid:33740454 PMCid:PMC8049514 Gilbert P.B., Montefiori D.C., McDermott A.B., et al.., 2022, Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial, Science, 375(6576): 43-50. https://doi.org/10.1126/science.abm3425 PMid:34812653 PMCid:PMC9017870 Giubilini A., 2021, Vaccination ethics, British medical bulletin, 137(1): 4-12. https://doi.org/10.1093/bmb/ldaa036 PMid:33367873 PMCid:PMC7799313 Ho C.W.L., 2022, Operationalizing "one health" as "one digital health" through a global framework that emphasizes fair and equitable sharing of benefits from the use of artificial intelligence and related digital technologies, Frontiers in Public Health, 10: 768977. https://doi.org/10.3389/fpubh.2022.768977 PMid:35592084 PMCid:PMC9110679 Jones R.P., and Ponomarenko A., 2022, System complexity in influenza infection and vaccination: Effects upon excess winter mortality, Infectious Disease Reports, 14(3): 287-309. https://doi.org/10.3390/idr14030035 PMid:35645214 PMCid:PMC9149983 Kennedy R., Ovsyannikova I., Palese P., and Poland G.A., 2020, Current challenges in vaccinology, Frontiers in Immunology, 11: 1181. https://doi.org/10.3389/fimmu.2020.01181 PMid:32670279 PMCid:PMC7329983 Khalil I., Walker R., Porter C.K., Muhib F., Chilengi R., Cravioto A., Guerrant R., Svennerholm A.M., Qadri F., Baqar S., Kosek M., Kang G., Lanata C., Armah G., Wierzba T., Hasso-Agopsowicz M., Giersing B., and Bourgeois A.L., 2021, Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access, Vaccine, 39(31): 4266-4277. https://doi.org/10.1016/j.vaccine.2021.04.018 PMid:33965254 PMCid:PMC8273896 Khan M., Amin A., Farid A., Ullah A., Waris A., Shinwari K., Hussain Y., Alsharif K., Alzahrani K., and Khan H., 2022, Recent advances in genomics-based approaches for the development of intracellular bacterial pathogen vaccines, Pharmaceutics, 15(1): 152. https://doi.org/10.3390/pharmaceutics15010152 PMid:36678781 PMCid:PMC9863128 Lopez-Siles M., Corral-Lugo A., and McConnell M.J., 2021, Vaccines for multidrug resistant Gram negative bacteria: Lessons from the past for guiding future success, FEMS Microbiology Reviews, 45(3): fuaa054. https://doi.org/10.1093/femsre/fuaa054
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==